Drug Therapy
Conference Coverage
RNA interference drug fitusiran looks effective in both hemophilia A and B
MELBOURNE – The RNA interference drug fitusiran is associated with significant reductions in bleeding rates in patients with hemophilia A and B,...
Conference Coverage
Medication overuse prevalent among U.S. migraine patients
PHILADELPHIA – Results from a U.S. survey showed an 18% prevalence of medication overuse among people with self-reported migraine symptoms.
Conference Coverage
Statins crush early seizure risk poststroke
BANGKOK – Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study.
Conference Coverage
Gum bacteria and Alzheimer’s: A hypothesis inches forward
LOS ANGELES – Results from a small trial saw neutralizing P. gingivalis associated with biomarker changes; a larger trial is planned.
News
Gynecologic surgeries linked with persistent opioid use
Nearly 7% of women received new opioid prescriptions months after common – and even minimally invasive – gynecologic procedures.
Conference Coverage
Nearly 20% of migraineurs use opioids for migraine
PHILADELPHIA – People with 4 or more migraine headache days per month are more likely to use opioids, compared with people with fewer migraine...
Conference Coverage
CARMELINA confirms linagliptin’s renal, CV safety, but it’s still third-line for type 2 diabetes
SAN FRANCISCO – The study was unusual among other DPP-4 trials in that almost 60% of the patients were older than 65, and 62.3% had impaired renal...
Latest News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.
News
Court halts rule requiring drug list pricing in advertising
Judge noted that the court understands what HHS wanted to do – but that it’s up to Congress to enact such a requirement.
News
Industry payments influence prescription choices
New research shows a link between industry payments by drug manufacturers to physicians and prescribing patterns for associated medications.